Bioqual(BIOQ)
$30.250.00 (0.00%)
BIOQ
Bioqual financials statements
$30.25
At close:0.00 (0.00%)
Want to see BIOQ full AI Analyst Report?
Bioqual (BIOQ) Ratios
19 Followers
Bioqual Ratios
BIOQ's free cash flow for Q1 2026 was $461.28K. For the 2026 fiscal year, BIOQ's free cash flow was decreased by $-67.02K and operating cash flow was $528.30K. See a summary of the company’s cash flow.
| Ratios | Aug 25 | Aug 24 | Aug 23 | May 23 | Aug 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.22 | 3.72 | 4.02 | 3.61 | 3.25 |
| Quick Ratio | 4.22 | 3.72 | 4.02 | 3.61 | 3.25 |
| Cash Ratio | 1.75 | 2.12 | 2.03 | 0.88 | 0.22 |
| Solvency Ratio | -0.05 | 0.06 | 0.16 | 0.28 | 0.52 |
| Operating Cash Flow Ratio | 0.06 | 0.35 | 1.22 | 0.99 | 0.03 |
| Short-Term Operating Cash Flow Coverage | 0.11 | 0.74 | 2.61 | 2.39 | 0.10 |
| Net Current Asset Value | $ -9.20M | $ 10.34M | $ 11.94M | $ 6.24M | $ 6.06M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.29 | 0.06 | 0.30 | 0.30 |
| Debt-to-Equity Ratio | 1.01 | 0.46 | 0.10 | 0.49 | 0.50 |
| Debt-to-Capital Ratio | 0.50 | 0.31 | 0.09 | 0.33 | 0.33 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.29 | 0.29 |
| Financial Leverage Ratio | 2.11 | 1.58 | 1.50 | 1.63 | 1.68 |
| Debt Service Coverage Ratio | -0.84 | 0.18 | 0.85 | 1.94 | 4.38 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.11 | 0.10 | 0.06 | 0.27 | 0.30 |
| Interest Debt Per Share | 36.57 | 18.49 | 4.01 | 20.71 | 20.94 |
| Net Debt to EBITDA | -9.58 | -2.77 | -3.96 | 1.63 | 1.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 3.59% | -3.88% | 12.68% | 20.11% | 19.66% |
| EBIT Margin | -11.19% | -3.88% | 0.81% | 1.81% | 9.94% |
| EBITDA Margin | -5.64% | 0.97% | 5.18% | 11.12% | 22.32% |
| Operating Profit Margin | -11.19% | -3.88% | -0.03% | 1.76% | 9.88% |
| Pretax Profit Margin | -9.30% | -2.63% | 0.81% | 1.81% | 9.94% |
| Net Profit Margin | -10.44% | -2.14% | 0.83% | 1.33% | 7.95% |
| Continuous Operations Profit Margin | -10.44% | -2.14% | 0.83% | 1.33% | 7.95% |
| Net Income Per EBT | 112.18% | 81.47% | 101.48% | 73.73% | 79.99% |
| EBT Per EBIT | 83.11% | 67.86% | -2426.15% | 102.75% | 100.68% |
| Return on Assets (ROA) | -6.09% | -1.84% | 0.85% | 1.36% | 8.30% |
| Return on Equity (ROE) | -12.86% | -2.90% | 1.28% | 2.22% | 13.96% |
| Return on Capital Employed (ROCE) | -7.20% | -3.89% | -0.04% | 2.08% | 12.19% |
| Return on Invested Capital (ROIC) | -6.85% | -2.93% | -0.04% | 1.44% | 9.22% |
| Return on Tangible Assets | -6.18% | -1.87% | 0.87% | 1.39% | 8.44% |
| Earnings Yield | -14.34% | -2.60% | 0.74% | 1.22% | 8.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.82 | 3.71 | 4.18 | 2.94 | 2.47 |
| Payables Turnover | 36.86 | 26.75 | 37.09 | 31.40 | 16.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.04 | 2.01 | 2.38 | 2.06 | 2.16 |
| Asset Turnover | 0.58 | 0.86 | 1.04 | 1.02 | 1.04 |
| Working Capital Turnover Ratio | 1.84 | 2.12 | 2.61 | 2.87 | 3.09 |
| Cash Conversion Cycle | 85.60 | 84.69 | 77.39 | 112.55 | 125.08 |
| Days of Sales Outstanding | 95.50 | 98.33 | 87.24 | 124.17 | 147.67 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 9.90 | 13.64 | 9.84 | 11.62 | 22.59 |
| Operating Cycle | 95.50 | 98.33 | 87.24 | 124.17 | 147.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.39 | 3.29 | 10.45 | 9.16 | 0.35 |
| Free Cash Flow Per Share | -0.07 | 3.03 | 9.79 | 6.66 | -5.11 |
| Dividend Paid and CapEx Coverage Ratio | 0.84 | 4.29 | 8.96 | 2.62 | 0.05 |
| Capital Expenditure Coverage Ratio | 0.84 | 12.33 | 15.67 | 3.67 | 0.06 |
| Operating Cash Flow Coverage Ratio | 0.01 | 0.18 | 2.61 | 0.44 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.06 | 0.16 | 0.13 | 0.00 |
| Free Cash Flow Yield | -0.23% | 6.72% | 13.50% | 8.77% | -7.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.97 | -38.46 | 134.26 | 81.72 | 11.90 |
| Price-to-Sales (P/S) Ratio | 0.73 | 0.82 | 1.11 | 1.09 | 0.95 |
| Price-to-Book (P/B) Ratio | 0.90 | 1.11 | 1.72 | 1.82 | 1.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -435.29 | 14.87 | 7.41 | 11.40 | -13.69 |
| Price-to-Operating Cash Flow Ratio | 82.71 | 13.67 | 6.94 | 8.30 | 199.80 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.12 | -3.20 | -0.97 | -0.70 |
| Enterprise Value Multiple | -22.47 | 82.15 | 17.45 | 11.43 | 5.36 |
| Enterprise Value | 50.66M | 38.94M | 52.90M | 79.61M | 79.15M |
| EV to EBITDA | -22.47 | 82.15 | 17.45 | 11.43 | 5.36 |
| EV to Sales | 1.27 | 0.80 | 0.90 | 1.27 | 1.20 |
| EV to Free Cash Flow | -758.55 | 14.39 | 6.04 | 13.30 | -17.31 |
| EV to Operating Cash Flow | 144.14 | 13.22 | 5.65 | 9.67 | 252.58 |
| Tangible Book Value Per Share | 35.08 | 39.27 | 40.90 | 40.72 | 40.97 |
| Shareholders’ Equity Per Share | 36.23 | 40.42 | 42.05 | 41.87 | 42.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.12 | 0.19 | -0.01 | 0.26 | 0.20 |
| Revenue Per Share | 44.66 | 54.64 | 65.44 | 69.75 | 73.96 |
| Net Income Per Share | -4.66 | -1.17 | 0.54 | 0.93 | 5.88 |
| Tax Burden | 1.12 | 0.81 | 1.01 | 0.74 | 0.80 |
| Interest Burden | 0.83 | 0.68 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 |
| SG&A to Revenue | 0.13 | 0.13 | 0.00 | 0.12 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.08 | -2.81 | 19.36 | 9.85 | 0.06 |
Currency in USD

